Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

HRSA 340B Prime Vendor Agreement

Active
HRSA-HSB-250-2014-AG(1)FMFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

N/A

NAICS

446110 - Pharmacies and Drug Stores

Place of Performance

5600 Fishers Ln. Room 14W19, ROCKVILLE, MD, 20857, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

2 updates
PhaseSolicitation
Posted

Presolicitation

Notice updated

The notice description changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Type Changed

Presolicitation → Solicitation

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Francis R. MurphyContracting Officer

Full Description

Show more
The Health Resources and Services Administration (HRSA) intends to solicit proposals with the intent of signing an Agreement with an organization having the capability to develop, maintain, and coordinate a Prime Vendor Program in accordance with Section 340B of the Public Health Service Act, Public Law 102-585 as amended "Limitation on Prices of Drugs Purchased by Covered Entities". Section 340B provides that drug manufacturers who sign a Pharmaceutical Pricing Agreement, as the manufacturers are required to do by Section 1927 (a) of the Social Security Act, with the Secretary of Health and Human Services agree to charge a price for covered outpatient drugs to covered entities that will not exceed the amount determined under a statutory formula (ceiling price). Section 340B also mandates the establishment of a Prime Vendor Program. The purpose of the 340B Prime Vendor is to develop, maintain and coordinate a program capable of distribution facilitation and other activities in support of the 340B Drug Pricing Program (340B Program) that bring value to 340B stakeholders. The offer that submits a technically-acceptable responsive proposal that offers the best value to member entities will be selected as the Prime Vendor. The Prime Vendor shall operate as an independent entity and not as an agent of the Government. No Federal funds will be awarded to the Prime Vendor under this Agreement. The Prime Vendor shall provide, directly or by subcontract, all drug/pharmaceutical items authorized under Section 340B for distribution to all member entities. The Prime Vendor shall negotiate sub-ceiling prices for the benefit of the member entities. HRSA reserves the right not to award an Agreement if it is determined that no organization meets the technical and business criteria enumerated in the HRSA Request for Agreement. A Request for Agreement HRSA-HSB- 250-2014-AG(1 )FM is anticipated to be released on or about 15 days from release of this notice. Offerors will be given thirty days from release of the Request for Agreement to submit their proposal. The solicitation will specify the actual due date. The solicitation will be available at this web site (www.fbo.gov) as an attachment to this announcement. It is the offeror's responsibility to monitor this site for amendments to this solicitation.

Similar Contracts

Same NAICS industry code

NAICS: 446110
Federal
Specialty Pharmacy Fulfillment of Lenalidomide (Revlimid)The contract involves the specialty pharmacy fulfillment and delivery of Lenalidomide (Revlimid), a medication used primarily in the treatment of certain cancers and blood disorders, to patients of the Department of Veterans Affairs (VA). The contractor is responsible for dispensing either branded or therapeutically equivalent versions of Lenalidomide in varying strengths. This service must comply with Risk Evaluation and Mitigation Strategies (REMS) protocols, ensuring safe and effective use of the medication. Essential contract activities include verifying prescriptions, conducting patient outreach to support medication adherence and understanding, securely packaging the medication, and ensuring delivery is confirmed by obtaining signatures upon receipt. This subcontract is issued by the 252-NETWORK Contract Office 12 under the Department of Veterans Affairs and aligns with NAICS code 446110, which typically covers pharmacies and drug stores. While specific performance location details and points of contact are not provided, the contract underscores the importance of compliance with federal safety standards and thorough patient management. The seamless coordination of prescription verification, patient communication, packaging, and secure delivery highlights the contractor’s critical role in supporting VA patients’ access to this specialized pharmaceutical therapy.
252-NETWORK Contract Office 12 (36C252)

POSTED

10 months ago

DEADLINE

N/A
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS